For example, Li et al. (2020) reported that circTLK1 was highly expressed in renal cell carcinoma (RCC) and could promote RCC progression through the miR-136–5p/CBX4 pathway, and circTLK1 could serve as a diagnostic molecules and therapeutic targets for renal cancer. Here, CBX4 is linked to renal cell carcinoma.